Publication: Acneiform Skin Lesions Associated With Cetuximab Therapy: Report of Two Cases
| dc.authorscopusid | 53165359300 | |
| dc.authorscopusid | 59157762600 | |
| dc.authorscopusid | 7004347982 | |
| dc.authorscopusid | 6603682965 | |
| dc.authorscopusid | 6601978714 | |
| dc.authorscopusid | 6603561910 | |
| dc.contributor.author | Yilmaz, Ö. | |
| dc.contributor.author | Özden, Müge Güler | |
| dc.contributor.author | Aydin, F. | |
| dc.contributor.author | Şentürk, N. | |
| dc.contributor.author | Cantürk, T. | |
| dc.contributor.author | Turanli, A.Y. | |
| dc.date.accessioned | 2020-06-21T09:27:40Z | |
| dc.date.available | 2020-06-21T09:27:40Z | |
| dc.date.issued | 2010 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Yilmaz] Özlem, Department of Dermatology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Özden] Müge Güler, Department of Dermatology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Aydin] Fatma, Department of Dermatology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Şentürk] Nilgün, Department of Dermatology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Cantürk] Tayyar, Department of Dermatology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Turanli] Ahmet Yaşar, Department of Dermatology, Ondokuz Mayis Üniversitesi, Samsun, Turkey | en_US |
| dc.description.abstract | Cetuximab, is an IgG1 chimeric monoclonal antibody type of epidermal growth factor receptor (EGFR). It is most commonly prescribed for metastatic colorectal cancer, administered alone or in combination with irinotecan-based chemotherapy regimens (Lee et al., 2008; Segaert et al., 2005; Segaert and Cutsem 2005; Scope et al., 2009). Acneiform eruption is the most common adverse effect with 80% of incidence (Segaert and Cutsem 2005; Lee et al., 2008). We report two cases of severe acneiform eruption induced by cetuximab with metastatic colorectal cancer. © 2010 OMU All rights reserved. | en_US |
| dc.identifier.doi | 10.5835/jecm.omu.27.03.004 | |
| dc.identifier.endpage | 119 | en_US |
| dc.identifier.issn | 1300-2996 | |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.scopus | 2-s2.0-80053977928 | |
| dc.identifier.startpage | 118 | en_US |
| dc.identifier.uri | https://doi.org/10.5835/jecm.omu.27.03.004 | |
| dc.identifier.volume | 27 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | Ondokuz Mayis Universitesi Tip Dergisi | en_US |
| dc.relation.journal | Journal of Experimental and Clinical Medicine (Turkey) | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Acneiform Eruption | en_US |
| dc.subject | Cetuximab | en_US |
| dc.subject | Chemotherapy | en_US |
| dc.subject | Colorectal Cancer | en_US |
| dc.subject | Irinotecan | en_US |
| dc.subject | Side Effect | en_US |
| dc.title | Acneiform Skin Lesions Associated With Cetuximab Therapy: Report of Two Cases | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
